AI-generated from publicly available materials.Seoul St. Mary's Hospital has implemented an automated system to enhance the efficiency of patient registration for cancer drug risk management programs, particularly for immunomodulatory drugs used in treating multiple myeloma.
The newly developed software, created with the assistance of AI by haematologists at the hospital's Multiple Myeloma Center, simplifies the previous manual process that required over 20 data fields to be filled out for each prescription. Now, clinicians can initiate the registration by simply entering a patient's registration number, which automatically populates necessary information such as personal details, diagnosis, and prescription history. This automation not only reduces administrative burdens but also minimizes the potential for data entry errors.
In terms of safety, the system incorporates checks to ensure that the registration number matches patient records, halting the process if discrepancies are found. This is particularly crucial for women of childbearing age, who must have a negative pregnancy test registered within 24 hours before receiving prescriptions for certain drugs, ensuring stringent safety measures are upheld.
This automation comes at a time when the incidence of multiple myeloma in South Korea is on the rise, highlighting the need for efficient management systems in healthcare settings. By alleviating the administrative workload and enhancing patient safety, Seoul St. Mary's initiative represents a significant step forward in integrating AI into healthcare practices. Furthermore, the hospital is exploring additional applications of this technology, indicating a commitment to ongoing innovation in patient care.